Misha Dagan, Shane Nanayakkara, William Chan, David C McGiffin, David M Kaye
{"title":"血管小,问题大:探讨肺动脉高压的肺微循环及评价方法。","authors":"Misha Dagan, Shane Nanayakkara, William Chan, David C McGiffin, David M Kaye","doi":"10.1016/j.ebiom.2025.105867","DOIUrl":null,"url":null,"abstract":"<p><p>Pulmonary microvascular dysfunction is central to the pathophysiology of pulmonary hypertension (PH), yet remains challenging to evaluate in clinical practice. This review outlines current and emerging methodologies for assessing the pulmonary microcirculation, including advanced imaging, computational modelling, and invasive haemodynamic techniques. Exercise right heart catheterisation, waveform analysis, and vasoreactivity testing provide indirect insights into microvascular health, while novel invasive approaches, such as pulmonary flow reserve and pulmonary microvascular resistance indices, offer the potential for more precise functional characterisation. Computational models incorporating CT-derived anatomical data and patient-specific haemodynamics may enhance early detection and phenotyping of PH. Although many of these tools remain in the research domain, their refinement and integration into clinical workflows could enable earlier diagnosis, personalised risk stratification, and monitoring of therapeutic response. Ultimately, translating these innovations into practice may allow for targeted interventions that address microvascular dysfunction at an earlier stage of disease progression.</p>","PeriodicalId":11494,"journal":{"name":"EBioMedicine","volume":"118 ","pages":"105867"},"PeriodicalIF":10.8000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12311541/pdf/","citationCount":"0","resultStr":"{\"title\":\"Small vessels, big problem: a dive into the pulmonary microcirculation in pulmonary hypertension and methods for evaluation.\",\"authors\":\"Misha Dagan, Shane Nanayakkara, William Chan, David C McGiffin, David M Kaye\",\"doi\":\"10.1016/j.ebiom.2025.105867\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Pulmonary microvascular dysfunction is central to the pathophysiology of pulmonary hypertension (PH), yet remains challenging to evaluate in clinical practice. This review outlines current and emerging methodologies for assessing the pulmonary microcirculation, including advanced imaging, computational modelling, and invasive haemodynamic techniques. Exercise right heart catheterisation, waveform analysis, and vasoreactivity testing provide indirect insights into microvascular health, while novel invasive approaches, such as pulmonary flow reserve and pulmonary microvascular resistance indices, offer the potential for more precise functional characterisation. Computational models incorporating CT-derived anatomical data and patient-specific haemodynamics may enhance early detection and phenotyping of PH. Although many of these tools remain in the research domain, their refinement and integration into clinical workflows could enable earlier diagnosis, personalised risk stratification, and monitoring of therapeutic response. Ultimately, translating these innovations into practice may allow for targeted interventions that address microvascular dysfunction at an earlier stage of disease progression.</p>\",\"PeriodicalId\":11494,\"journal\":{\"name\":\"EBioMedicine\",\"volume\":\"118 \",\"pages\":\"105867\"},\"PeriodicalIF\":10.8000,\"publicationDate\":\"2025-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12311541/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"EBioMedicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.ebiom.2025.105867\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/7/25 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"EBioMedicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ebiom.2025.105867","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/7/25 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
Small vessels, big problem: a dive into the pulmonary microcirculation in pulmonary hypertension and methods for evaluation.
Pulmonary microvascular dysfunction is central to the pathophysiology of pulmonary hypertension (PH), yet remains challenging to evaluate in clinical practice. This review outlines current and emerging methodologies for assessing the pulmonary microcirculation, including advanced imaging, computational modelling, and invasive haemodynamic techniques. Exercise right heart catheterisation, waveform analysis, and vasoreactivity testing provide indirect insights into microvascular health, while novel invasive approaches, such as pulmonary flow reserve and pulmonary microvascular resistance indices, offer the potential for more precise functional characterisation. Computational models incorporating CT-derived anatomical data and patient-specific haemodynamics may enhance early detection and phenotyping of PH. Although many of these tools remain in the research domain, their refinement and integration into clinical workflows could enable earlier diagnosis, personalised risk stratification, and monitoring of therapeutic response. Ultimately, translating these innovations into practice may allow for targeted interventions that address microvascular dysfunction at an earlier stage of disease progression.
EBioMedicineBiochemistry, Genetics and Molecular Biology-General Biochemistry,Genetics and Molecular Biology
CiteScore
17.70
自引率
0.90%
发文量
579
审稿时长
5 weeks
期刊介绍:
eBioMedicine is a comprehensive biomedical research journal that covers a wide range of studies that are relevant to human health. Our focus is on original research that explores the fundamental factors influencing human health and disease, including the discovery of new therapeutic targets and treatments, the identification of biomarkers and diagnostic tools, and the investigation and modification of disease pathways and mechanisms. We welcome studies from any biomedical discipline that contribute to our understanding of disease and aim to improve human health.